XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Bausch Health Companies Inc. Shareholders’ Equity (Deficit)
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning Balance (in shares) at Dec. 31, 2020     355,400,000        
Beginning Balance at Dec. 31, 2020 $ 605 $ 535 $ 10,227 $ 454 $ (8,013) $ (2,133) $ 70
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     4,000,000.0        
Common shares issued under share-based compensation plans 22 22 $ 90 (68)      
Share-based compensation 128 128   128      
Employee withholding taxes related to share-based awards (52) (52)   (52)      
Release of foreign currency translation losses upon disposal of assets held for sale 340 340       340  
Noncontrolling interest distributions (10)           (10)
Net (loss) income (937) (948)     (948)   11
Other comprehensive (loss) income (130) (131)       (131) 1
Ending Balance (in shares) at Dec. 31, 2021     359,400,000        
Ending Balance at Dec. 31, 2021 (34) (106) $ 10,317 462 (8,961) (1,924) 72
Increase (Decrease) in Shareholders' Equity              
Proceeds from B+L initial public offering, net of costs (Note 2) 675 (190)   (327)   137 865
Common shares issued under share-based compensation plans (in shares)     2,500,000        
Common shares issued under share-based compensation plans 3 3 $ 74 (71)      
Share-based compensation 126 126   126      
Employee withholding taxes related to share-based awards (31) (31)   (31)      
Noncontrolling interest distributions (11)           (11)
Net (loss) income (212) (225)     (225)   13
Other comprehensive (loss) income $ (256) (269)       (269) 13
Ending Balance (in shares) at Dec. 31, 2022 361,898,846   361,900,000        
Ending Balance at Dec. 31, 2022 $ 260 (692) $ 10,391 159 (9,186) (2,056) 952
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     3,300,000        
Common shares issued under share-based compensation plans     $ 32 (32)      
Share-based compensation 132 132   132      
Employee withholding taxes related to share-based awards (24) (24)   (24)      
Vesting of B+L equity compensation 0 (21)   (21)     21
Noncontrolling interest distributions (9)           (9)
Net (loss) income (611) (592)     (592)   (19)
Other comprehensive (loss) income $ 170 175       175 (5)
Ending Balance (in shares) at Dec. 31, 2023 365,238,917   365,200,000        
Ending Balance at Dec. 31, 2023 $ (82) $ (1,022) $ 10,423 $ 214 $ (9,778) $ (1,881) $ 940